- Mayo Clinic posts 6.8% margin in 2025
- Listen to the Latest ‘KFF Health News Minute’
- FDA clears AI tool to predict delivery date
- Corewell Health posts 1.6% operating margin, grows revenue to $17.6B — 7 things to know
- Corewell Health posts 1.6% operating margin, grows revenue to $17.6B — 7 things to know
- Woodside Health acquires Arizona facility
- New York safety-net hospital board chair to resign after 10 months
- New York physician sentenced to 7 years for unlawful drug distribution
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Cooper University Health Care Selects hellocare.ai as Enterprise Platform for AI-Assisted Intelligent Hospital Rooms, Virtual Nursing, and Virtual Sitting
- How to Get Ready For Daylight Saving Time
- A-Fib Drug Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Effective Sunscreen Protection Can Cost $40 A Year
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Federal Aid for Lead Cleanup Is Receding. That’s a Problem for Cash-Strapped Cities.
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- Think bigger – Turning AI from Trends to Long-Term Transformation
- UnityPoint Health hospital names market chief nursing officer
- OhioHealth builds well-being programs to reshape caregiver culture
- Washington hospital staff vote ‘no confidence’ in management company
- U of Mississippi Medical Center restores phone lines after cyberattack
- 13 health system IT leadership moves
- UF Health taps new outpatient senior VP
- UAMS names new director of cardiovascular medicine division
- CMS’ add-on billing code boosts specialist pay: Study
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- Florida medical center to expand with ASC
- New Jersey woman charged with practicing unlicensed dentistry
- CMS extends hospital-at-home waivers for 5 years: What ASCs need to know
- 100+ organizations call on CMS to revise 2027 MA rates
- The retention breakthrough anesthesia needs
- Oklahoma advances interstate compact bill
- Brown University Health names new chief of cardiac surgery
- UNC Health Appalachian offers psychiatric physician training program
- Former PepperPointe Partnerships COO joins DPO
- The Smilist expands into Virginia
- Physician-led orthopedic ASC opens in Florida
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- Pennsylvania county cuts ribbon on $19.8M mental health diversion center
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- In 1 state, large hospitals dominate 340B's net savings
- 15 dentists making headlines
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- PDS Health added de novos across 3 states in February
- Novant posts 4.8% operating margin in 2025
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- Cleveland Clinic posts $913M operating income, 5% margin — 7 things to know
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer
- Clinician Engagement: The Operating Lever Behind Margin and Throughput
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- 11 behavioral health executive moves to know
- 3 behavioral healthcare M&A deals in 2026
- Iowa dentist surrenders license
- Temple University gets approval for $3.19M rural dental clinic
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- Blood Test Can Predict Short-Term Survival Among Seniors
- How the Brain Learns to Have Seizures During Sleep
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Partnering to Advance Drug Delivery Innovation
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
Increasing penalties for fentanyl, and classifying them as Schedule I. That class is defined as drugs with no current medical use with high potential for abuse and/or addiction."The ultimate impact of this bill is taking fentanyl permanently away from pain and surgery patients.
What could possibly go wrong?
by Joyce Frieden, Washington Editor, MedPage Today May 26, 2023
The House passed a bill Thursday that proponents say is designed to reduce the number of people who become addicted to fentanyl, but opponents say it won't solve the problem and will just increase the number of people incarcerated for drug-related crimes.
The Halt All Lethal Trafficking of Fentanyl (HALT Fentanyl) Act passed by a vote of 289-133, with 215 Republicans and 74 Democrats voting in favor. The measure would:
- Permanently put fentanyl-related substances into Schedule I of the Controlled Substances Act. Currently, fentanyl is on Schedule I through Dec. 31, 2024, thanks to a temporary scheduling order issued by the Drug Enforcement Administration (DEA).
- Establish a new, alternative registration process for Schedule I research that is funded by HHS or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the FDA.
- Clarify that offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues. For example, offenses involving 100 g or more of a fentanyl-related substance will trigger a 10-year mandatory minimum prison term.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain situations, and waiving the requirement for a new inspection in some cases.
"With today's bipartisan vote in the House to advance the HALT Fentanyl Act, we are one step closer to curbing the devastating fentanyl poisoning crisis and saving American lives," Rep. Bob Latta (R-Ohio) said in a statement. "Illicit fentanyl is now the leading cause of death for people in the United States aged 18 to 49 ... This permanent labeling change is significant and needed because it will help get fentanyl-related substances off our streets and out of our communities. I now urge the Senate to take up this bill and send it to the president's desk to be signed into law."
House Speaker Kevin McCarthy (R-Calif.) applauded the bill's law enforcement provisions. "Due to the Biden administration's incompetence at the border, fentanyl has flowed into American communities and destroyed lives," he said in a statement. "The HALT Fentanyl Act is one needed tool to help stop the flow of fentanyl and provides law enforcement agencies the authority they need to help them adequately address this crime."
The Biden administration also praised the bill, specifically the permanent scheduling provision and a provision to make fentanyl research easier. "These two provisions are critical components of the Biden-Harris Administration's 2021 recommendations to Congress to combat the supply of illicit FRS [fentanyl-related substances] and save lives," the White House said in a statement. "The administration calls on Congress to pass all of these critical measures to improve public safety."
But others were not so happy. Despite multiple extensions of the Schedule I designation, "overdoses have not gone down, and we have unfortunately [not] made a dent in the incidence of opioid use disorders," Rep. Frank Pallone, Jr. (D-N.J.), ranking member of the House Energy & Commerce Committee, said on the House floor.
"Fentanyl and synthetic opioids continue to flood into the country. In testimony before our committee, the DEA administrator noted that DEA seized more than 50 million fake pills and 10,000 pounds of fentanyl in 2022 ... The HALT Fentanyl Act is a partisan distraction from the hard, bipartisan work that actually has to be done to address a long standing, intractable problem that faces our communities," he said.
"We simply cannot incarcerate our way out of a public health crisis," Pallone said. "The HALT Fentanyl Act does not provide any resources for research, prevention, treatment, recovery, or harm reduction. It also does not provide law enforcement or public health agencies with any additional resources to detect and intercept illicit drugs entering the country."
Several advocacy groups agreed. "Passage of the HALT Fentanyl Act and the draconian expansion of mandatory minimum sentencing for fentanyl-related substances contained in it would be a reckless repetition of the costly mistakes of the war on drugs that disproportionately impacts Black and Brown communities and creates the conditions for even more harmful illicit substances to enter the drug supply," Drew Gibson, director of advocacy for AIDS United, said in a statement.
"Any hope that we have of ending the overdose, HIV, and viral hepatitis epidemics in the United States lies in an embrace of evidence-based best practices and a rejection of the punitive and racially inequitable policies that have destroyed millions of lives over the last half-century," Gibson added.
"In passing the HALT Fentanyl Act, the House seems intent on doubling down on the same failed strategies that got us here to begin with," Maritza Perez Medina, director of the Office of Federal Affairs at the Drug Policy Alliance, said in a statement. "Increasing criminal penalties and expanding the use of mandatory minimums, as this bill does, has never reduced the supply or demand of illicit drugs. Instead, it only exacerbates racial disparities in the criminal legal system and creates the conditions for an even more unknown, and more potent, drug supply to flourish."
AIDS United, the Drug Policy Alliance, and other organizations are supporting the Support, Treatment, and Overdoses Prevention of Fentanyl Overdoses (STOP Fentanyl Overdoses) Act sponsored by Rep. Annie Kuster (D-N.H.). That bill would expand testing for fentanyl and related substances; increase information-sharing by public health departments and law enforcement in order to identify public health threats and prevent overdoses; and improve access to overdose reversal medications and substance use disorder treatment.
On the other side of the Capitol, the Senate version of the HALT Fentanyl Act was introduced by Sen. Bill Cassidy (R-La.) on March 30. It has been referred to the Senate Judiciary Committee but no other action has been taken on it.
https://www.medpagetoday.com/washington-watch/washington-watch/104730
And not a word about the border.
Joyce Frieden oversees MedPage Today’s Washington coverage, including stories about Congress, the White House, the Supreme Court, healthcare trade associations, and federal agencies. She has 35 years of experience covering health policy.
Michigan testimony on border concerns did contribute to this bill.
The Detroit News in February highlighted Rebecca Kiessling. New Detroit Congressman Shri Thanadar gets a line at the end.
'You're not protecting our children': Rochester Hills mom testifies about 2 sons' fentanyl deaths
Feb. 28, 2023Washington― A Michigan mother tearfully told House lawmakers the story Tuesday of her two sons' deaths from an accidental overdose of the opioid fentanyl, saying the government isn't doing enough to combat the opioid crisis and halt illegal drugs at the border.
"My children were taken away from me," saidRebecca Kiessling, a family law attorney and conservative activist from Rochester Hills.
"This should not be politicized. It's not about race. Fentanyl doesn't care about race. You talk about welcoming those crossing our border seeking protection? You're welcoming drug dealers across our border. You're giving them protection. You're not protecting our children."
Kiessling said her two sons, Caleb, 20, and Kyler, 18, died July 29, 2020, from fentanyl poisoning, along with 17-year-old Sophia Harris, when they took what they thought were Percocet pills that turned out to contain the drug fentanyl, a potent synthetic opioid drug that can be lethal in tiny amounts.
She said her sons' "dealer" was saved by a dose of the overdose-reversing spray Narcan and is serving prison time. Lorenzo Brabo was sentenced in 2021 to eight to 15 years in prison for providing the fentanyl that led to the three overdose deaths, according to reports.
"I don't use the term 'drug overdose' because this was not an overdose. This was murder," she said. "This is a war. Act like it. Do something."
Kiessling testified Tuesday morning before the Republican-led U.S. House Committee on Homeland Security, urging Congress and the White House to take the flow of illegal drugs over the Southern border more seriously. Prior to her sons' deaths, Kiessling said she didn't know what fentanyl was.
"I had heard of the opioid epidemic. I thought, you know, people are getting prescription drugs and getting addicted and then getting it on the streets, and that it affects their ability to work. I didn't know that people were dying," she said.
"I didn't know that my boys were taking anything that could kill them. They didn't think that they were either. They thought that they were safe with pills. ... But the government knew. The government's known for years and years."
Opioid overdose trends
Michigan experienced a 23% increase in opioid-related deaths from 1,768 in 2019 to 2,171 in 2020, when Kiessling's two sons died, according to state Department of Health and Human Services' statistics. The number rose to 2,539 deaths in 2021, a 17% jump. U.S. opioid-related deaths rose from 68,630 in 2020 to 80,411 in 2021, according to theNational Institute on Drug Abuse.
Kiessling highlighted the tally of drug-related deaths the year that Caleb was born — 20,000 in 2000 — and the surge of 100,000 like deaths in 2020.
"If we had Chinese troops lining up along our Southern border with weapons aimed at our people, with weapons of mass destruction aimed at our cities, you damn well know you would do something about it," she said.
"We have a weather balloon from China going across the country. Nobody died, and everybody's freaking out about it. But 100,000 die every year, and nothing's being done. Not enough is being done."
Kiessling started crying as she read from a paper written by Kyler weeks before his death, advising to "stay away from drugs and alcohol."
"It's not worth it," he wrote.
Kyler, who had graduated from high school the day before his death, also wrote in a list that he wanted to start working more to stay focused, have a better relationship with his parents, to report to all drug tests and "find another method to cope that works for me," according to his mother.
Caleb, Kiessling said, had started speaking in schools to encourage kids not to try drugs. He wrote a testimony to share with them, saying that he'd "dabbled" in drugs but had stayed away from crack and heroine because he'd grown up "watching my birth mother ruin her life and watch all her friends pass away from heroin overdoses."
Kiessling said later in the hearing that the boys' birth mother died six months after they did.
Lawmakers respond
Committee Chairman Mark Green, R-Tennessee, blamed the Biden administration for border policies that he said have contributed to the "surge" in migrants at the border, "and the drug cartels have taken advantage of the situation."
Kiessling's sons died in 2020, when Donald Trump was president and was trying to extend a wall across the Southern border.
The Biden administration has touted itsoverdose epidemic strategy, which has included spending $1.5 billion on grants for aid to treatment programs and law enforcement. The U.S. Department of the Treasury is using sanctions to target the global fentanyl supply chain, especially in Mexico, administration officials have said.
The Biden administration in February also proposed a rule that migrants seeking to enter the United States will be assumed inadmissible if they "circumvent available, established pathways to lawful migration," including entering the country between ports of entry or arriving at a port of entry without a scheduled appointment.The proposal also rejects those who fail to seek protection in countries through which they pass while heading to the United States.
Green asked Kiessling how her community has been affected by the opioid crisis. She replied that some parents and siblings whom she knows from support groups had committed suicide.
"It's devastating families," she said. "It's been very difficult for my (three) daughters. One daughter, she went off to Michigan State and came home after a semester. It was just too painful."
One of Kyler's friends approached her at a restaurant last summer and said he'd stopped doing any kind of drugs in response to his death, Kiessling said.
"He said, 'I want you to know that your son's death started a movement in our hometown, so that when people show up with pills, they're ostracized, and they're condemned,' he said," Kiessling recounted. "But, you know, for how long? How many of the kids in the high schools now know about my son's deaths?"
Rep. Marjorie Taylor Greene, R-Georgia, also lamented the surge in fentanyl deaths, saying it's become a top cause of death for Americans ages 18 to 45 years old.
"This is unforgivable," said Greene, thanking Kiessling for sharing her story and saying her sons' deaths "should never have happened."
Kiessling responded in part by criticizing witness testimony from the Cato Institute's David Bier, who suggested that policymakers should focus on demand and not supply to reduce drug deaths.
"What I'm hearing him saying is, 'They asked for it.' Seriously, are you kidding me?" Kiessling said. "We need to protect our children. They didn't ask for that. This wasn't demand that they wanted the fentanyl. They thought they were getting Percocet, OK?"
Rep. Donald Payne Jr., D-New Jersey, said most illegal drugs are smuggled through ports of entry into the United States "unfortunately" by U.S. citizens, and usually hidden in vehicles, cargo, or on a person in the hopes "it won't be detected."
Payne suggested lawmakers should focus on what policy changes can be made to allow personnel at ports of entry to focus on the interdiction of drugs.
It was the first full committee hearing for freshman Rep. Shri Thanedar, D-Detroit, a former businessman and Indian immigrant who spoke of the importance of the Northern border.
"Unfortunately, a shortage of pathways for immigration has made our borders very difficult to manage. CBP has had to rely on temporary duty assignments to surge employees where they are most needed, which has often pulled resources away from the northern border," Thanedar said. "As an immigrant myself, I'm a proud example of how immigrants contribute to American society."
Melissa Nann Burke covers Washington for The Detroit News, including Michigan's congressional delegation, the White House and U.S. Supreme Court.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.


















